ZVRA logo

Zevra Therapeutics (ZVRA) Total Expenses

Annual Total Expenses

$77.06 M
+$42.00 M+119.79%

31 December 2023

ZVRA Total Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Expenses

$31.00 M
+$2.76 M+9.76%

30 September 2024

ZVRA Quarterly Total Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ZVRA Total Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+119.8%+69.8%
3 y3 years+326.5%+640.4%
5 y5 years+42.0%+276.7%

ZVRA Total Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+326.5%at high+640.4%
5 y5 yearsat high+326.5%at high+887.9%
alltimeall timeat high+1533.4%at high+1872.1%

Zevra Therapeutics Total Expenses History

DateAnnualQuarterly
Sept 2024
-
$31.00 M(+9.8%)
June 2024
-
$28.24 M(+18.1%)
Mar 2024
-
$23.91 M(-14.8%)
Dec 2023
$77.06 M(+119.8%)
$28.08 M(+53.8%)
Sept 2023
-
$18.26 M(+24.0%)
June 2023
-
$14.72 M(-8.0%)
Mar 2023
-
$16.01 M(+41.2%)
Dec 2022
$35.06 M(+67.6%)
$11.34 M(+19.3%)
Sept 2022
-
$9.50 M(-63.6%)
June 2022
-
$26.07 M(+347.6%)
Mar 2022
-
$5.82 M(+7.4%)
Dec 2021
$20.92 M(+15.8%)
-
Dec 2021
-
$5.42 M(+29.5%)
Sept 2021
-
$4.19 M(-32.0%)
June 2021
-
$6.15 M(+19.3%)
Mar 2021
-
$5.16 M(-7.6%)
Dec 2020
$18.07 M(-45.5%)
$5.58 M(+77.9%)
Sept 2020
-
$3.14 M(-27.3%)
June 2020
-
$4.32 M(-14.3%)
Mar 2020
-
$5.03 M(-13.0%)
Dec 2019
$33.18 M
$5.79 M(-29.7%)
Sept 2019
-
$8.23 M(+5.6%)
DateAnnualQuarterly
June 2019
-
$7.79 M(-31.5%)
Mar 2019
-
$11.37 M(+22.7%)
Dec 2018
$54.27 M(+62.6%)
$9.27 M(-43.2%)
Sept 2018
-
$16.32 M(+17.4%)
June 2018
-
$13.91 M(-5.8%)
Mar 2018
-
$14.77 M(+81.2%)
Dec 2017
$33.37 M(-3.2%)
$8.15 M(-15.2%)
Sept 2017
-
$9.61 M(+16.9%)
June 2017
-
$8.22 M(+11.4%)
Mar 2017
-
$7.38 M(-31.9%)
Dec 2016
$34.47 M(+51.1%)
$10.84 M(+46.6%)
Sept 2016
-
$7.39 M(-20.3%)
June 2016
-
$9.28 M(+33.1%)
Mar 2016
-
$6.97 M(-4.3%)
Dec 2015
$22.81 M(+38.7%)
$7.28 M(+12.4%)
Sept 2015
-
$6.48 M(+8.8%)
June 2015
-
$5.96 M(+92.4%)
Mar 2015
-
$3.10 M(-58.7%)
Dec 2014
$16.44 M(+248.5%)
$7.49 M(+72.6%)
Sept 2014
-
$4.34 M(+42.5%)
June 2014
-
$3.04 M(+93.7%)
Mar 2014
-
$1.57 M
Dec 2013
$4.72 M
-

FAQ

  • What is Zevra Therapeutics annual total expenses?
  • What is the all time high annual total expenses for Zevra Therapeutics?
  • What is Zevra Therapeutics annual total expenses year-on-year change?
  • What is Zevra Therapeutics quarterly total expenses?
  • What is the all time high quarterly total expenses for Zevra Therapeutics?
  • What is Zevra Therapeutics quarterly total expenses year-on-year change?

What is Zevra Therapeutics annual total expenses?

The current annual total expenses of ZVRA is $77.06 M

What is the all time high annual total expenses for Zevra Therapeutics?

Zevra Therapeutics all-time high annual total expenses is $77.06 M

What is Zevra Therapeutics annual total expenses year-on-year change?

Over the past year, ZVRA annual total expenses has changed by +$42.00 M (+119.79%)

What is Zevra Therapeutics quarterly total expenses?

The current quarterly total expenses of ZVRA is $31.00 M

What is the all time high quarterly total expenses for Zevra Therapeutics?

Zevra Therapeutics all-time high quarterly total expenses is $31.00 M

What is Zevra Therapeutics quarterly total expenses year-on-year change?

Over the past year, ZVRA quarterly total expenses has changed by +$12.74 M (+69.78%)